Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Multi-herb Kampo formula
Japanese Kampo formula studied for dementia agitation and insomnia.
Yokukansan is a traditional Japanese Kampo formula composed of seven herbs, primarily used for neuropsychiatric symptoms such as agitation in dementia and pediatric night crying. Its clinical evidence is limited (Grade C) but supported by traditional use. Key active compounds include geissoschizine methyl ether, atractylenolide, and glycyrrhizin, which contribute to its serotonergic and glutamatergic modulation.
Yokukansan acts as a partial 5-HT1A receptor agonist, enhancing serotonergic transmission, and modulates glutamatergic activity by reducing extracellular glutamate levels. Geissoschizine methyl ether is a major active compound with 5-HT1A agonistic properties, while glycyrrhizin may contribute to anti-inflammatory effects. The formula also exhibits anxiolytic and neuroprotective effects through these pathways.
Japanese Kampo formula studied for dementia agitation and insomnia.
Yokukansan is a traditional Japanese Kampo formula composed of seven herbs, primarily used for neuropsychiatric symptoms such as agitation in dementia and pediatric night crying. Its clinical evidence is limited (Grade C) but supported by traditional use. Key active compounds include geissoschizine methyl ether, atractylenolide, and glycyrrhizin, which contribute to its serotonergic and glutamatergic modulation.
Yokukansan acts as a partial 5-HT1A receptor agonist, enhancing serotonergic transmission, and modulates glutamatergic activity by reducing extracellular glutamate levels. Geissoschizine methyl ether is a major active compound with 5-HT1A agonistic properties, while glycyrrhizin may contribute to anti-inflammatory effects. The formula also exhibits anxiolytic and neuroprotective effects through these pathways.